ARCHIVES

After a “humble” start at NCI, von Eschenbach set unachievable goal.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

DCT Advisors OK 2 Grant Programs, Disapprove One, In NCI Effort To Improve Funding For Clinical Research

March 8, 1991

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008

FDA Approves Kytril For Post-Operative Nausea

October 25, 2002

House Science Committee Chairman Questions NIH Budget Increases.

February 2, 2001

DCT Board Gives Concept Approval to Recompetition Of In Vitro Assay For New Drug Screening Program

February 24, 1984

JRB Wins $3.6 Million Support contract

November 29, 1974